{"id":1000654,"date":"2026-09-04T08:16:34","date_gmt":"2026-09-04T12:16:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/"},"modified":"2026-09-04T08:16:34","modified_gmt":"2026-09-04T12:16:34","slug":"alumis-to-participate-in-upcoming-september-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/","title":{"rendered":"Alumis to Participate in Upcoming September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Sept.  04, 2026  (GLOBE NEWSWIRE) &#8212; Alumis Inc. (Nasdaq: ALMS), a late-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Wells Fargo 21st Annual Healthcare Conference<br \/><\/strong>September 8-10, 2026, Boston, MA<br \/>Fireside chat: Tuesday, September 8, 2026 at 11:00 am ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Cantor Global Healthcare Conference <\/strong><br \/>\n          <br \/>September 9-11, 2026, New York, NY <br \/>Fireside chat: Wednesday, September 9, 2026 at 2:10 pm ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Morgan Stanley Global Healthcare Conference<\/strong><br \/>\n          <br \/>September 14-16, 2026, New York, NY<br \/>Fireside chat: Monday, September 14, 2026 at 7:45 am ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Baird 2026 Global Healthcare Conference <\/strong><br \/>\n          <br \/>September 15, 2026, New York, NY <br \/>Presentation: Tuesday, September 15, 2026 at 10:15 am ET<\/p>\n<\/li>\n<\/ul>\n<p>To access the live webcasts please visit the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U50H7Bzvu-Y7EoNnfhKzJpekPgOWFZH2lczSWOvC2GZvQoRj3-ROoVOVq3g2BfQSVcY1DGhFuJ8CHgoWmVSel-RViRUc4z0WoGqe32C99oHZaFMZcKFLnSWrW9j3DuJalWZVhAxH11wgxwFVGsvjfsvPUhaNENrglZazDPqgpJKzRvykGSV6W4_FLWeMICzLdT1HVvBJ3s-mtv6fhJg6AihNGxZBF4Er08hseggDV0GGSgbLRCBn0mRemPhi-XstDUMHuiF9J0lZQ48OF1Z3GjktNQtoZZ-UCJhGzlY5U50dnEn4AtlzLSfTDOtW9aq9nkg9tY25Go4rYXM0tvIXO_RqZ8EiOyjLPy1uBL3LrVZlXVsIr4badvRLMBZ8SzLDe6YWBONlMmWEfZNW_4RsqiBLLwDYzcYj4YU-t_hkZoblCg-cYrf7pdTSOXTj09Zu\" rel=\"nofollow\" target=\"_blank\">Events<\/a>\u201d page of the \u201cInvestors&#8221; section of the Alumis website. Webcast replays will be archived on the company&#8217;s website for 90 days.<\/p>\n<p>\n        <strong>About Alumis<\/strong><br \/>\n        <br \/>Alumis is a late-stage biopharmaceutical company developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated diseases. Leveraging its proprietary data analytics platform and precision approach, Alumis is developing a pipeline of oral tyrosine kinase 2 inhibitors, consisting of envudeucitinib, formerly known as ESK-001, for the treatment of systemic immune-mediated disorders, such as moderate-to-severe plaque psoriasis and systemic lupus erythematosus, and A-005, its central nervous system penetrant TYK2 inhibitor, with initial development focused on Parkinson\u2019s disease and additional neuroinflammatory, neurodegenerative and peripheral immune-mediated disease indications under evaluation. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rEhd1QJ5i4HMq12UwUdmL69ONaaRBHiwUdx0_pWEDd-cpXzO6IFUIO1OQKiZTuS-EyUL5HgA3vMumxv7VDYtNiKrH03KGHu1g3G-QcqD7rqr6qXX9WctLcR9TmNT_kTpG33B-J8FLbuDu2Ryunha0kqZoc2FKZ5KtRwqeWYkujNnSRaAKxt_qqmKy24p5OU_Dsgl9rrkWli45BJC2jyp6tY7I0uqd7XjEO0C_-XMvA-PjxfuNMFs_dY8S3J6urWR\" rel=\"nofollow\" target=\"_blank\">www.alumis.com<\/a>\u00a0or follow us on LinkedIn or X.<\/p>\n<p>\n        <strong>Forward Looking Statements<\/strong><br \/>\n        <br \/>This press release may contain forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These include, without limitation, statements regarding Alumis\u2019 participation at upcoming conferences. Alumis explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.<\/p>\n<p>\n        <strong>Alumis Contact Information<\/strong><br \/>\n        <br \/>Teri Dahlman<br \/>Red House Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4nRL2dEKdpxx6Ptt3YcKUzpok2A3mXvPcJFuUUXN9J3VC8aeD2YR9CkldZ321r7xg--4wUt9t05xhJRj9Wd-TDbN1Lqz1X8oAsb6Jx6lPsI=\" rel=\"nofollow\" target=\"_blank\">teri@redhousecomms.com<\/a><\/p>\n<p>Joyce Allaire<br \/>LifeSci Advisors <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XG7eJgvlip6taZ0zOmCDGT95hnjfwP-59tX32SgTaNKMbNVtYBA9UdQaTscKPHIVdxz-ucKz0jQLh4hQhjBd1fq7VVDwOy9jQTWKouCU0NNqDSW7qV85WSb1NbhmUyLI\" rel=\"nofollow\" target=\"_blank\">jallaire@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTg4NjU1ZTUtOWRjOC00YTU0LThhYjgtMWFmMmE5ZDBhMjc1LTEzMDI3NTItMjAyNi0wOS0wNC1lbg==\/tiny\/Alumis-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) &#8212; Alumis Inc. (Nasdaq: ALMS), a late-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences: Wells Fargo 21st Annual Healthcare ConferenceSeptember 8-10, 2026, Boston, MAFireside chat: Tuesday, September 8, 2026 at 11:00 am ET Cantor Global Healthcare Conference September 9-11, 2026, New York, NY Fireside chat: Wednesday, September 9, 2026 at 2:10 pm ET Morgan Stanley Global Healthcare Conference September 14-16, 2026, New York, NYFireside chat: Monday, September 14, 2026 at 7:45 am ET Baird 2026 Global Healthcare Conference September 15, 2026, New York, NY Presentation: Tuesday, September 15, 2026 at 10:15 am ET To access &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alumis to Participate in Upcoming September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1000654","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alumis to Participate in Upcoming September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alumis to Participate in Upcoming September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) &#8212; Alumis Inc. (Nasdaq: ALMS), a late-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences: Wells Fargo 21st Annual Healthcare ConferenceSeptember 8-10, 2026, Boston, MAFireside chat: Tuesday, September 8, 2026 at 11:00 am ET Cantor Global Healthcare Conference September 9-11, 2026, New York, NY Fireside chat: Wednesday, September 9, 2026 at 2:10 pm ET Morgan Stanley Global Healthcare Conference September 14-16, 2026, New York, NYFireside chat: Monday, September 14, 2026 at 7:45 am ET Baird 2026 Global Healthcare Conference September 15, 2026, New York, NY Presentation: Tuesday, September 15, 2026 at 10:15 am ET To access &hellip; Continue reading &quot;Alumis to Participate in Upcoming September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-04T12:16:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alumis to Participate in Upcoming September Investor Conferences\",\"datePublished\":\"2026-09-04T12:16:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/\"},\"wordCount\":320,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/\",\"name\":\"Alumis to Participate in Upcoming September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=\",\"datePublished\":\"2026-09-04T12:16:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alumis-to-participate-in-upcoming-september-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alumis to Participate in Upcoming September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alumis to Participate in Upcoming September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Alumis to Participate in Upcoming September Investor Conferences - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) &#8212; Alumis Inc. (Nasdaq: ALMS), a late-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences: Wells Fargo 21st Annual Healthcare ConferenceSeptember 8-10, 2026, Boston, MAFireside chat: Tuesday, September 8, 2026 at 11:00 am ET Cantor Global Healthcare Conference September 9-11, 2026, New York, NY Fireside chat: Wednesday, September 9, 2026 at 2:10 pm ET Morgan Stanley Global Healthcare Conference September 14-16, 2026, New York, NYFireside chat: Monday, September 14, 2026 at 7:45 am ET Baird 2026 Global Healthcare Conference September 15, 2026, New York, NY Presentation: Tuesday, September 15, 2026 at 10:15 am ET To access &hellip; Continue reading \"Alumis to Participate in Upcoming September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-04T12:16:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alumis to Participate in Upcoming September Investor Conferences","datePublished":"2026-09-04T12:16:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/"},"wordCount":320,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/","name":"Alumis to Participate in Upcoming September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=","datePublished":"2026-09-04T12:16:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMTQ1OSM3ODE4MTk3IzIyOTEyMDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alumis-to-participate-in-upcoming-september-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alumis to Participate in Upcoming September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1000654"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000654\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1000654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1000654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1000654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}